Jeffrey S Farrow Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Jeffrey S Farrow is Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 22,431 shares of TARS, which is worth approximately $1.09 Million. The most recent transaction as insider was on Mar 20, 2025, when has been sold 1,186 shares (Common Stock) at a price of $50.11 per share, resulting in proceeds of $59,430. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.4K

23.68% 3M change

n/a 12M change

Total Value Held $1.09 Million

Jeffrey S Farrow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2025	SELL Open market or private sale	$59,430 $50.11 p/Share	1,186 Reduced 5.02%	22,431 Common Stock
Mar 19 2025	SELL Open market or private sale	$59,439 $47.4 p/Share	1,254 Reduced 5.04%	23,617 Common Stock
Mar 18 2025	SELL Open market or private sale	$59,436 $46.29 p/Share	1,284 Reduced 4.91%	24,871 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	8,019 Added 23.47%	26,155 Common Stock
Jun 18 2024	SELL Open market or private sale	$286,924 $27.47 p/Share	10,445 Reduced 36.55%	18,136 Common Stock
Jun 17 2024	BUY Exercise of conversion of derivative security	-	27,881 Added 49.38%	28,581 Common Stock

Also insider at

GBT

Global Blood Therapeutics, Inc. Healthcare

Chief Financial Officer

JSF

Jeffrey S Farrow

Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account